e-mail: Dkrakow@mednet.ucla.edu The short-rib polydactyly syndromes (SRPS) are a genetically heterogeneous group of autosomal recessive skeletal ciliopathies that fall with the larger group of inherited osteochondrodysplasias (1) . Characteristic findings in SRPS include short horizontal ribs, short limbs and polydactyly. Historically, four distinct SRP types have been recognized: SRP I (Saldino-Noonan syndrome, MIM 263530); SRP II (Majweski syndrome, MIM 263520); SRP III (Verma-Naumoff syndrome, MIM 263510); and SRP IV (Beemer-Langer syndrome, MIM 269860). The current nosology groups SRPS within the 'Ciliopathies with major skeletal involvement' category and subcategorizes SRP types I and III together (1) . The short-rib dysplasia group also includes chondroectodermal dysplasia (Ellis-van Creveld syndrome or EVC, MIM 225500), oral-facial-digital syndrome type 4 (Mohr-Majewski syndrome, MIM 258860), asphyxiating thoracic dystrophy (ATD or Jeune syndrome, MIM 208500), and thoracolaryngopelvic dysplasia (Barnes syndrome, MIM 187760). Although each SRP subtype was characterized by distinct features, significant phenotypic overlap among cases of different subtypes as well as transitional findings shared among the subtypes led to the suggestion as early as 1977 that SRPS should be considered a single group of disorders that presents along a spectrum of variable phenotypic expression (2) (3) (4) (5) (6) .
Classification of SRPS cases had primarily been based on the clinical phenotype and radiographic findings in each individual case, with little molecular information available. The identification of mutations in genes that encode proteins involved in ciliary function has facilitated correlating the specific molecular defect with the SRPS subtypes. Mutation analysis has revealed extensive locus and allelic heterogeneity, identifying defects in multiple components of the ciliary apparatus including the dynein motor complex [DYNC2H1 (OMIM 603297) (OMIM 603191) , among the skeletal ciliopathies. In addition, some related ciliopathies have also been shown to result from mutations in these genes; cranioectodermal dysplasia (OMIM 614378 and 613610) due to abnormalities in WDR19 and WDR35, respectively, and Bardet-Biedl syndrome (OMIM 209901) due to defects in IFT172. However, thus far no genes have been associated with SRP type I (7).
SRP type I was first characterized in 1972 (8) as a new syndrome delineated in two stillborn siblings with severe thoracic dystrophy, micromelia, hypoplastic long bones, and multiple internal congenital anomalies. Radiographic features included short, horizontal ribs forming a small, narrow chest (more severe than that seen in the other SRP types), polydactyly in most cases, poorly ossified bones in the hands, duplicated calcaneal ossification, marked shortening of the long bones with pointed metaphyses, absent fibulae, small pelvic bones, underdeveloped thoracic and cervical vertebral bodies, vertebral body clefts and advanced sternal bone age despite an overall picture of delayed ossification (4, (8) (9) (10) (11) . SRP types I and III share some radiographic features, although SRP III has less severe narrowing of the thorax and more rounded metaphyses than seen in SRP I (9) .
Extraskeletal clinical manifestations in SRP I vary widely from case to case, but reported characteristics include a hydropic appearance, dolichocephaly, natal teeth, micrognathia, and internal organ anomalies in the genitourinary, cardiovascular, gastrointestinal, and pulmonary systems (8, 11) . While multiple studies have reported a predominance of female cases in SRP I, compared with an equal sex distribution in SRP III (12) , this was contradicted in a case review of published cases (3). While SRP types I and III are usually classified together, the features distinguishing type I from type III include overall more severe clinical and radiographic abnormalities in SRP type I, including greater organ system involvement.
Mutations in DYNC2H1 are the most common cause of both SRP and ATD, accounting for about 50% of cases (McInerney-Leo 2014, Valerie, Amy, lots of refs). DYNC2H1 encodes the 4307 amino acid heavy chain of the cytoplasmic dynein 2 complex. Loss-of-function or missense mutations in DYNC2H1 occur throughout the length of the gene/protein and most cases have private mutations. The cytoplasmic dynein 2 complex serves as the motor for retrograde IFT-A transport, and thus is responsible for transport of cargo away from the tip of the cilia. The IFT complex serves as an adaptor between cargoes and IFT motors.
Skeletal ciliopathies result from mutations in the genes that encode proteins involved in intraflagellar transport, IFT, a specialized transport process that drives macromolecules from the base to the tip of the cilium (anterograde transport) and from the tip of the cilium back to the cell body (retrograde transport). Transport is mediated by multiprotein complexes that include IFT complexes, the BBSome, IFT motors, and associated cargos (13) . Heterotrimeric kinesin-II and cytoplasmic dynein-2 are the IFT motors responsible for anterograde and retrograde transport, respectively. The dynein-2 motor complex consists of the heavy chain (DYNC2H1), an intermediate chain (D2IC), a light intermediate chain (D2LIC), and a light chain (LC). The IFT-A complex consists of proteins (IFT144, IFT140, IFT139, IFT122, IFT121, and IFT43) that act as adaptors between the dynein motor and associated cargos (14) . DYNC2H1 plays a direct role in contacting and translocating the dynein 2 complex along the microtubules and loss of the motor leads to accumulation of IFT-B (anterograde) particles that cannot be properly recycled (15, 16) . In an analysis of a cohort of patients with skeletal ciliopathies we identified three cases of SRP type I and describe the phenotypic and radiographic findings, and the molecular basis, of the phenotype, which in each case resulted from compound heterozygosity for DYNC2H1 mutations.
Materials and methods
Under an approved UCLA human subjects protocol consent was obtained for all individuals and exome sequence analysis carried out at the University of Washington Center for Mendelian Genomics using published methods (17) . Briefly, the samples were barcoded, captured using the NimbleGen SeqCap EZ Exome Library v2.0 probe library targeting 36.5 Mb of the genome, and sequenced on the Illumina GAIIx platform with 50 bp paired-end reads. Novoalign was used to align the sequence data to the human reference genome (NCBI build 37) and the Genome Analysis Toolkit (GATK) was used for post-processing and variant calling according to GATK Best Practices recommendations. For each sample, 96% of the targeted bases were covered by at least 10 independent reads and 90% of the targeted bases were covered by at least 20 independent reads. Variants were identified under an autosomal recessive model and filtered against dbSNP137, NIEHS EGP exome samples (v.0.0.8), exomes from the NHLBI Exome Sequencing Project (ESP6500), 1000 genomes (release 3.20120430), and in-house exome samples. Variants were further compared with known disease-causing mutations in HGMD (2012.2), were annotated using VAX (18) and mutation pathogenicity was predicted using the programs Polyphen (19) , Sift (20) , Condel (21), and CADD (22) . Allele frequencies were calculated based on the frequency of the allele in the 1000 Genomes Project and Exome Variant Server (ESP). Mutations were confirmed by bidirectional Sanger sequencing of amplified DNA from each proband. Sequence trace files were aligned and analyzed using Sequencher.
Results

Clinical presentation of SRP I cases
The three affected fetuses (International Skeletal Dysplasia Registry reference numbers R05-103, R96-212 and R00-264) all presented in utero. In two cases (R05-103 and R96-212), the affected fetuses were identified in the second trimester and underwent termination of pregnancy at 16 and 18 weeks, respectively. Postnatal evaluation showed a consistent phenotype that included a very narrow thorax, polydactyly of all limbs, and abdominal ascites. In addition, each affected individual had multiple craniofacial dysmorphisms (Table 1) . Case R00-264 presented with the most extensive organ system involvement, which included cleft lip and palate, as well as anomalies of the cardiovascular, gastrointestinal, and genitourinary systems as summarized in Table 1 . This individual also had hydrops fetalis. Similarly, case R05-103 also presented with hydrops fetalis, ascites and nuchal edema (Table 1 ) along with marked pulmonary hypoplasia (lung weight/body weight ratio of 0.001, with normal >0.03 (50th percentile at 18 weeks gestational age) (25) . There was limited clinical information available for R96-212 because no autopsy was performed (Table 1) . However, like the other cases, abdominal protuberance and ascites and a very narrow thorax were observed along with multiple craniofacial anomalies (Table 1) .
Radiographic presentation of SRP I cases
All three cases shared radiographic features that are detailed in Table 2 and Figs. 1 and 2 . Ossification of the calvarium, metacarpals, metatarsals, and all phalanges (feet and hands) was severely delayed in all three cases. In the vertebral column, hypoplastic vertebrae, mild platyspondyly with severely widened intervertebral disc spaces and coronal clefts were observed. There was micromelia with bilateral shortening of all long bones in both the upper and lower extremities. Each individual had only 11 ribs visible on X-ray, all of which were horizontal and extremely short. Pelvic abnormalities included ilia with decreased height and increased width. The lower extremities showed ovoid tibiae and underdeveloped or absent fibulae. Two cases exhibited bilateral polydactyly and one case had left hand and foot polydactyly. One case had calcaneal duplicate ossification.
DYNC2H1 mutations cause SRP I
The exome data were filtered to identify all variants in the genes known to be associated with the skeletal ciliopathies. In each of the three SRP I cases, the only skeletal ciliopathy gene in which there were two pathogenic variants found was DYNC2H1 (NM_001080463), and the affected individuals were each compound heterozygotes for different mutations in the gene (Table 3 and Fig. 3 ). Case R00-264 was heterozygous for a mutation in exon 42 (c.6834G>T) predicted to cause the amino acid substitution p.Trp2278Cys and alter the third ATP binding and hydrolysis domain of the protein.
The second mutation was in exon 74 (c.10886G>C) and is predicted to cause the amino acid substitution p.Arg3629Pro. Case R05-103B harbored mutations in exons 40 (c.6387G>T) and 52 (c.8339T>C), predicted Intervertebral disc. to cause the amino acid substitutions p.Trp2129Cys and p.Leu2780Ser, respectively. Both missense mutations are located within ATP binding and hydrolysis domains (AAA1 and AAA4, respectively). Case R96-212 was heterozygous for a mutation in exon 28 (c.4267C>T) predicted to cause the amino acid substitution p.Arg1423Cys, located in the stem domain, and a nonsense mutation in exon 70 (c.10594C>T) introducing a stop at codon 3532. All six mutations occurred at sites that are highly conserved among species and have CADD scores over 15, predicting the changes to be highly deleterious (22) .
Discussion
Shortened limbs, narrow thoraxes, and polydactyly are characteristic of all four types of SRP, which define the perinatal lethal end of the skeletal ciliopathy spectrum, the SRPs. SRP I represents the most severe form of SRP. On radiographic analysis, Saldino and Noonan reported pointed metaphyses in the long bones as characteristic of SRP I (8). We observed pointed metaphyses in one individual and there was variability in the shape of the metaphyseal ends, suggesting that differentiating SRPS based on whether the metaphyses are rounded or pointed may not be that helpful. Lachman and Taybi (11) reported absent fibulae as being characteristic of SRP I, an insight supported by the cohort presented here, in which there were absent fibulae bilaterally in one individual and very small, dysplastic fibulae in the two others. Other reported radiographic findings in SRP type I such as platyspondyly, coronal clefts, and poor mineralization of the cervical vertebral bodies were seen in these cases, suggesting that there are multiple radiographic findings that help to characterize SRP I ( Table 2) . The three fetuses presented with significant ascites and hydrops fetalis at early gestational ages. In addition, cardiovascular, gastrointestinal, renal and genital anomalies were identified, showing the important role of DYNC2H1 and cilia function during fetal development. These abnormalities included failure of proper organogenesis, particularly of the gastrointestinal and genitourinary systems (Table 1) . Craniofacial abnormalities included cleft lip (overt cleft and midline notching of the superior lip/alveolar ridge) and palate in two individuals.
AIl three SRP I cases studied resulted from compound heterozygosity for mutations in DYNC2H1, the heavy chain of the cytoplasmic dynein 2 complex, the motor for retrograde IFT transport. All of the mutations are very rare, consistent with the low frequency of SRP in the population, with four of the mutations having not been observed either among SRP cases or reported in the public sequence databases. Five of the mutations are missense changes and all alter highly evolutionarily conserved residues, consistent with pathogenicity. All six mutations were predicted to be deleterious by multiple programs that estimate the effect on protein function. Three of the six mutations were missense changes affecting one of the six ATP binding and hydrolysis domains of the protein, indicating that disruption of the catalytic function of the dynein complex can have dramatic effects on skeletal and organ system development. The clearest evidence of pathogenicity was found in case R96-212, who was a compound heterozygote for a null mutation and a missense change (p.Arg1423Cys) that introduced an unpaired cysteine, and thus a structural alteration, into the stem domain of the dynein 2 complex. The latter change was previously identified in a case of SRP II (23) . However, while finding two mutations in all three cases strongly supports pathogenicity in SRP I, it remains unclear from the genotypes why the particular mutation combinations observed had such a profound clinical outcome.
The molecular genetic data support the classification of SRP I and III together, which has been proposed previously based on radiographic and clinical phenotype. While mutations in at least 15 genes have been associated with SRPS, aside from their common involvement in cilia function, precisely how the specific alterations in each of these genes, many with non-overlapping roles in cilia biology, produce SRPS remains unresolved. Among SRPS-associated genes, DYNC2H1 is the most commonly involved locus (24) and DYNC2H1 mutations have been found in a broad spectrum of skeletal ciliopathies ranging from the perinatal lethal SRP types I, II, and III to non-lethal ATD cases. Particularly for the missense mutations, which alter residues throughout the protein and affect multiple functional domains, it remains challenging to understand how each mutation exerts its phenotypic effect. However the findings presented here now support DYNC2H1 as the primary candidate gene to consider when counseling families in which SRP I has occurred.
